Welcome to Library
Annual Reports
RMRIMS News Bulletine
Publications List of Dr. Niyamat Ali Siddiqui

 

1

Bhunia GS, Chatterjee N,  Kumar V, Siddiqui NA, Mandal R, Das P and Kesari S. Delimitation of kala-azar risk areas in the district of Vaishali in Bihar (India) using a geo-environmental approach. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2012; 107(5): 609-620.

2

Banjara MR, Hirve S, Siddiqui NA, Kumar N, Kansal S, Huda MM, Das P, Rijal S, Gurung CK, Malaviya P, Arana B, Kroeger A and Mondal D. Visceral Leishmaniasis clinical management in endemic districts of India, Nepal and Bangladesh. Journal of Tropical Medicine, 2012; 2012: 126093. (Epub 2012 May 9).

3

Das VNR, Ranjan A, Pandey K, Singh D, Verma N, Das S, Lal CS, Sinha NK, Verma RB, Siddiqui NA, and Das P. Short Report: Clinico-Epidemiologic Profile of a Cohort of Post–Kala-Azar Dermal Leishmaniasis Patients in Bihar, India. Am. J. Trop. Med. Hyg., 2012; 86(6): 959–961.

4

Pandey K, Das VN, Singh D, Das S, Lal CS, Verma N, Bimal S, Topno RK, Siddiqui NA, Verma RB, Sinha PK and Das P. Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India. J Clin Microbiol. 2012; 50(4): 1478-1479. (Epub 2012 Jan 25).

5

Das VN, Siddiqui NA, Verma RB, Topno RK, Singh D, Das S, Ranjan A, Pandey K, Kumar N and Das P. Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes. Trans R Soc Trop Med Hyg, 2011; 105(11): 661-666. (Epub 2011 Sep 25).

6

Kumar N, Singh SP, Mondal D, Joshi A, Das P, Sundar S, Kroeger A, Hirve S, Siddiqui NA and Boelaert M. How do health care providers deal with kala-azar in the Indian subcontinent?. Indian J Med Res, 2011; 134(3): 349-55.

7

Siddiqui NA, Kumar N, Ranjan A, Pandey K, Das VNR, Verma RB and Das P. Awareness about Kala-azar disease and related preventive attitudes and practices in a highly endemic rural area of India.  Southeast Asian journal of tropical medicine and public health, 2010; 41(1): 1-12.

8

Sarnoff R, Desai J, Desjeux P, Mittal A, Topno R, Siddiqui NA, Pandey A, Sur D and Das P. Visceral leishmaniasis supplement: the economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India.  Trop Med Int Health. 2010 May 6. [Epub ahead of print]

9

Das P, Samuels S, Desjeux P, Mittal A, Topno R, Siddiqui NA, Sur D, Pandey A and Sarnoff R. Annual incidence of visceral leishmaniasis in an endemic area of Bihar, India. Tropical Medicine and International Health, 2010; 15(suppl. 2):1-8.

10

Mubayi A, Castillo-Chavez C, Chowell G, Kribs-Zaleta C, Ali Siddiqui N, Kumar N and Das P. Transmission dynamics and underreporting of Kala-azar in the Indian state of Bihar. Journal of Theoretical Biology, 2010; 262(1): 177-185.


11

Topno RK, Das VN, Ranjan A, Pandey K, Singh D, Kumar N, Siddiqui NA, Singh VP, Kesari S, Kumar N, Bimal S, Kumar AJ, Meena C, Kumar R and Das P. Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India. Am J Trop Med Hyg, 2010; 83(3): 502-506.

12

Das VN, Pandey K, Verma N, Lal CS, Bimal S, Topno RK, Singh D, Siddiqui NA, Verma RB and Das P. Development of Post Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosinetreated visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 2009; 80(3): 336-338.


13

Das VN, Siddiqui NA, Pandey K, Singh VP, Topno RK, Singh D, Verma RB, Ranjan A, Sinha PK and Das P. A controlled, randomized nonblinded clinical trial to assess the effi cacy of  mphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India. Therapeutics and Clinical Risk Management, 2009; 5: 117–124.


14

Kumar N, Siddiqui NA, Verma RB and Das P. Knowledge About Sandflies in Relation to Public and Domestic Control Activities of Kala-azar in Rural Endemic Areas of Bihar. Journal of Communicable Diseases, 2009, 41(2): 121-128.

15

Pandey k, Sinha PK, Das VN, Nawin Kumar,.Bimal S, Verma RB, Verma N, Lal CS, Topno RK, Siddiqui NA, Singh D and Das P. Tuberous sclerosis with visceral leishmaniasis: a case report. Journal of Medical Case Reports, 2009; 3: 9027.


16

Topno RK, Pandey K, Das VN, Kumar N, Bimal S, Verma RB, Siddiqui NA, Singh D, Kumar R, Kumar P, Ranjan A, Das P and Sinha PK. Visceral Leishmaniasis in pregnancy – role of Amphotericin B. Ann. Trop. Med. & Parasitol, 2008; 102(3): 267-270.

17

Das VN, Siddiqui NA, Kumar N, Verma N, Verma RB, Dinesh DS, Kar SK and Das P . A pilot study on the status of lymphatic filariasis in a rural community of Bihar. J Commun Dis, 2006; 38(2): 169-75.


18

Das VN, Pandey K, Kumar N, Hassan SM, Bimal S, Lal CS, Siddiqui NA and Bhattacharya SK. Visceral leishmaniasis and tuberculosis in patients with HIV co-infection. Southeast Asian J Trop Med Public Health, 2006; 37(1): 18-21.


19

Kumar N, Siddiquiu NA, Verma RB, Rabidas VNR, Verma N and Kar SK . A pilot study on mother's knowledge and their perception about control, transmission and treatment of Lymphatic Filariasis in a rural community of Bihar. Journal of Parasitic Diseases, 2003; 27: 33-37.

20

Kumar N, Siddiqui NA, Verma R and Kar S.K. Women's perceptions on kala-azar. Journal of Parasitic Disease. 2002; 26: 38-41.

21

Das VN, Ranjan A, Sinha AN, Verma N, Lal CS, Gupta AK, Siddiqui NA and Kar SK. A randomized clinical trial of low dosage combination of pentamidine and allopurinol in the treatment of antimony unresponsive cases of visceral leishmaniasis. Journal of Association of Physician of India, 2001; 49: 609-613.